Navigation Links
NUCRYST Announces Management Realignment and R&D Portfolio Change
Date:4/30/2008

Turner for her contributions during her tenure at NUCRYST, and we wish her success in her future endeavors."

About Clostridium difficile

Clostridium difficile (also called C. difficile or C. diff) is a bacterium that is recognized as the major causative agent of colitis (inflammation of the colon) and diarrhea that may occur following antibiotic intake. C. difficile infection represents one of the most widespread hospital infections around the world. C. difficile may complicate the course of ulcerative colitis or Crohn's disease and it is responsible for a significant occurrence of diarrhea in AIDS patients. According to the Centers for Disease Control and Prevention, each year in the United States C. difficile is responsible for tens of thousands of cases of diarrhea and at least 5,000 deaths.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark. Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101 for use in medical devices and as an active pharmaceutical ingredient.

Acticoat(TM) is a trademark of Smith & Nephew plc

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

This news release contains forward-l
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NUCRYST Announces Senior Management Change
2. NUCRYST Pharmaceuticals announces year-end results
3. NUCRYST Pharmaceuticals announces 2007 third quarter results
4. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
5. NUCRYST and Smith & Nephew Revise Agreements
6. West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast
7. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
8. GSK Announces Changes to Corporate Executive Team
9. Summit VetPharm Announces New Distributor Partnership with Webster Veterinary
10. Psychemedics Corporation Announces First Quarter Results
11. InfoLogix Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... PA (PRWEB) August 27, 2014 What’s ... of this year’s 87th Annual Scripps National Spelling Bee? ... for a tour of internationally renowned Wills Eye Hospital.     ... like to be an ophthalmologist one day. , Wills ... eye surgery and the latest hi-tech visual diagnostic testing. ...
(Date:8/27/2014)... NC. SonaCare Medical, LLC, the global leader in ... 15 HIFU devices over the past twelve months pointing ... company’s ablation technology. , “It is truly exciting ... the past year, especially since we are now heading ... active sales period,” says Mike Klein, CEO of SonaCare ...
(Date:8/27/2014)... -- A new study finds that continuous positive airway ... sleep apnea. CPAP is widely used to treat ... which the airway relaxes and narrows during sleep, causing ... daytime drowsiness. CPAP keeps the airway open ... nose via a mask that is worn during sleep. ...
(Date:8/27/2014)... (HealthDay News) -- Overconfident people are better at convincing ... and therefore are more likely to get promotions and ... researchers added that these "self-deceived" people are also more ... greater risks. And finally, people who underestimate themselves ... to the British researchers. Their findings were published Aug. ...
(Date:8/27/2014)... each receive $100,000 in funding to launch pilot programs ... for patients served by community health centers. The program ... and is part of the group,s effort to reach ... over receiving regular screening for colorectal cancer by 2018. ... are: Port Royal, South Carolina; New Haven, Connecticut; and ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3
... -- Poor memory and problems with other mental skills may be ... suggests. Researchers gave a word recall memory test to 17,851 ... to measure the brain,s executive functioning skills. The participants, who were ... a stroke, were then contacted twice a year for up to ...
... source of cocaine, is speeding up destruction of rainforests ... and animal diversity, scientists are reporting in a new ... for establishing larger protected areas to help preserve biodiversity, ... . Liliana M. Dvalos and colleagues note ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, Feb. ... necessary in women with early breast cancer who also undergo a ... in the Feb. 9 issue of the Journal of the ... sentinel nodes -- those lymph nodes to which the cancer spreads ...
... study from Utrecht and Cambridge Universities has for the ... the tongue in volunteers negatively affects a person,s ability ... findings are published this week in the journal ... addition, the effects of testosterone administration are predicted by ...
... University medical device startup that has developed a system ... closing the beating heart during cardiac surgery has received ... the Georgia Tech/Emory technology and will further develop the ... procedure required for delivering therapeutic devices to the heart ...
... -- An injection of local anesthetic can be made ... researchers report. They reviewed 18 studies that included ... injections led to a "clinically meaningful reduction in pain," ... not; whether the shot was administered subcutaneously (under the ...
Cached Medicine News:Health News:Could Poor Memory Signal Raised Stroke Risk? 2Health News:Cocaine production increases destruction of Colombia's rainforests 2Health News:Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study 2Health News:Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study 3Health News:Extra testosterone reduces your empathy 2Health News:Apica Cardiovascular receives $5.1 million investment for improved heart surgery system 2Health News:Apica Cardiovascular receives $5.1 million investment for improved heart surgery system 3
(Date:8/27/2014)... , Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the ... announces the following financial results for its third quarter of ... 30, 2014: , Revenue of $1,291,378, a 13% ... , Net loss for the quarter of $240,156 compared to ... prior year For the nine months ended ...
(Date:8/27/2014)... 27, 2014  After the February 2014 launch of ... solution for medical practices and management companies, Prime ... new software. "The feedback has been great," ... "The sheer number of demos and new sign-ups is ... for these types of software features." ...
(Date:8/27/2014)... , Aug. 27, 2014 Sinovac Biotech Ltd. (NASDAQ: ... China , today announced the results of the Company,s ... 2014 in Beijing , PRC. The required quorum, ... The Company,s shareholders approved the following proposals:  ... Lam Lo , Simon Anderson , Kenneth Lee ...
Breaking Medicine Technology:Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2
... derivative compound series,show highly selective PI3K-inhibition which ... 16, 2007 /PRNewswire-FirstCall/ - AEterna Zentaris,Inc. , ... on,endocrine therapy and oncology, today presented an ... pyridopyrazine derivatives,with high selectivity for PI3K inhibition, ...
... With Improved Potential to,Battle Their Disease, PASADENA, ... Inc., a majority-owned subsidiary of Arrowhead,Research Corporation ... will be featured in a poster presentation ... (AACR) Annual,Meeting. In particular, this poster includes ...
Cached Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
... Collection was inspired by the professional male who ... be appreciated by all men especially those between ... incorporates a complete range of materials, shapes and ... advantage of the best that fashion and technology ...
Hush Puppies Pups feature vibrant colors and playful styling for children. Kids love the added comfort while parents love the durable designs found in every Hush Puppies Pups frame....
... and playful, the Thalia ... for girls who love ... colorful accents and sparkling ... this exciting collection.Thalia Girls ...
... updated shapes and traditional colors in their eyewear. ... to wear deigns in rectangles and teacup shapes. ... of metal fronts and zyl temples. Frames feature ... added comfort and exceptional fit., ,Building on the ...
Medicine Products: